The Neuroendocrine Tumor Research Foundation, Boston, MA, the leading funder of neuroendocrine tumor (NET) research, today announced its Spark Hope campaign to raise a total of $10 million to accelerate the search for more treatment options and cures for this poorly understood cancer.
“Our knowledge of neuroendocrine tumors lags dramatically behind other cancer types,” said Elyse Gellerman, chief executive officer, Neuroendocrine Tumor Research Foundation (NETRF). “We owe it to the more than 177,000 Americans living with NETs to intensify the urgency with which we investigate this cancer.” Both Aretha Franklin and Steve Jobs passed from neuroendocrine tumors.
The Spark Hope campaign, a $10 million fundraising effort, is fueled by a challenge grant generously given by the Margie and Robert E. Petersen Foundation. Automobile publishing giant Robert E. Petersen passed away from NETs in 2007. The Foundation has provided NETRF the opportunity to launch the most ambitious research effort ever undertaken to control and cure neuroendocrine cancers. When gifts are made to NETRF, the Petersen Foundation will match dollar for dollar to $5 million through July 2021.
“NETRF funds high caliber, meaningful research, which helps us understand how NETs develop and identify ways to combat them,” said Joe Li, MD, chair, Board of Directors, NETRF.
“NETRF is grateful to the Petersen Foundation for laying the groundwork for expanding our philanthropic support and inspiring donors to participate while doubling their impact on NET research,” said Susan Payson, chief development officer, NETRF.
Neuroendocrine tumors (NETs) form in the body’s hormone-producing cells. Though these cells can be found throughout the body, tumors most commonly form in the digestive tract or lungs.